Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
| Autor: | Boettler, Tobias, Newsome, Philip N, Mondelli, Mario U, Maticic, Mojca, Cordero, Elisa, Cornberg, Markus, Berg, Thomas |
|---|---|
| Přispěvatelé: | [Boettler,T] Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [Newsome,PH] National Institute for Health Research, Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. [Newsome,PH] Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. [Mondelli,MU] Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy. [Maticic,M] Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Slovenia. [Maticic,M] Faculty of Medicine, University of Ljubljana, Slovenia. [Cordero,E] Department of Medicine, University of Seville, Clinical Unit of Infectious Diseases University Hospital Virgen del Rocio, Institute of Biomedicine, Sevilla, CSIC, Spain. [Cornberg,M] Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany. [Cornberg,M] Centre for Individualised Infection Medicine (CIIM), Hannover, Germany. [Berg,T] Division of Hepatology, Clinic and Polyclinic for Gastroenterology, Hepatology, Infectious Diseases, and Pneumology, University Hospital Leipzig, Leipzig, Germany., CiiM, Zentrum für individualisierte Infektionsmedizin, Feodor-Lynen-Str.7, 30625 Hannover. |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
ACE-I
angiotensin-converting enzyme inhibitor NAFLD non-alcoholic fatty liver disease Health Care::Health Services Administration::Patient Care Management::Delivery of Health Care [Medical Subject Headings] NASH non-alcoholic steatohepatitis PIs protease inhibitors Analytical Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures Operative::Transplantation::Organ Transplantation::Liver Transplantation [Medical Subject Headings] Terapéutica Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics [Medical Subject Headings] AST aspartate aminotransferase EGD esophagogastroduodenoscopy ACE2 angiotensin-converting enzyme 2 SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 MELD model for end-stage liver disease ULN upper limit of normal ALT alanine aminotransferase RdRp RNA-dependent RNA polymerase NUC nucleoside analogue COVID-19 coronavirus disease 2019 Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Chronic Disease [Medical Subject Headings] SARS-CoV-2 Trasplante de hígado Enfermedad crónica COVID-19 ERC endoscopic retrograde cholangiography Hepatopatías Diseases::Digestive System Diseases::Liver Diseases [Medical Subject Headings] ACLF acute-on-chronic liver failure Prestación de atención de salud HCC hepatocellular carcinoma |
| Zdroj: | JHEP reports : innovation in hepatology Netherlands |
| Popis: | The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a severe disease course. It remains unclear at this point to what extent chronic liver diseases should be considered as risk factors, due to a shortage of appropriate studies. However, patients with advanced liver disease and those after liver transplantation represent vulnerable patient cohorts with an increased risk of infection and/or a severe course of COVID-19. In addition, the current pandemic requires unusual allocation of healthcare resources which may negatively impact the care of patients with chronic liver disease that continue to require medical attention. Thus, the challenge hepatologists are facing is to promote telemedicine in the outpatient setting, prioritise outpatient contacts, avoid nosocomial dissemination of the virus to patients and healthcare providers, and at the same time maintain standard care for patients who require immediate medical attention. Yes |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|